Baum Charles M Insider Trades

Insider Trading History

Track insider trading activity for Baum Charles M. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Acrivon Therapeutics
Acrivon Therapeutics ACRV
Director
Holding Value $14.1k 9,366 shares
Last Trade
May 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.5k 9,366 shares
$1.65
$1.51
Acrivon Therapeutics
Acrivon Therapeutics ACRV
Director
Holding Value $30.6k 20,275 shares
Last Trade
Jun 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.3k 20,275 shares
$1.20
$1.51
PMV Pharmaceuticals
PMV Pharmaceuticals PMVP
Director
Holding Value $38.9k 33,500 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31.8k 33,500 shares
$0.95
$1.16
Poseida Therapeutics
Poseida Therapeutics PSTX
Director
Holding Value $0 0 shares
Last Trade
Jan 08, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$542k 57,000 shares
$9.50
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
Director
Holding Value $0 0 shares
Last Trade
Jan 08, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$260k 27,350 shares
$9.50
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
Director
Holding Value $0 0 shares
Last Trade
Jan 08, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$260k 27,350 shares
$9.50
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
Director
Holding Value $0 0 shares
Last Trade
Jan 08, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$707k 78,600 shares
$9.00
$9.50
Acrivon Therapeutics
Acrivon Therapeutics ACRV
Director
Holding Value $30.6k 20,275 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$132k 20,275 shares
$6.52
$1.51
Poseida Therapeutics
Poseida Therapeutics PSTX
Director
Holding Value $747k 78,600 shares
Last Trade
Jun 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$76.9k 27,350 shares
$2.81
$9.50
PMV Pharmaceuticals
PMV Pharmaceuticals PMVP
Director
Holding Value $78.3k 67,500 shares
Last Trade
Jun 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$111k 67,500 shares
$1.65
$1.16
Mirati Therapeutics
Mirati Therapeutics MRTX
Founder, President, And CEO
Holding Value $0 0 shares
Last Trade
Jan 23, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$5.89M 100,273 shares
$58.70
$58.70
Mirati Therapeutics
Mirati Therapeutics MRTX
Founder, President, And CEO
Holding Value $6.72M 114,482 shares
Last Trade
Jan 23, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$7.16M 123,389 shares
$58.00
$58.70
Mirati Therapeutics
Mirati Therapeutics MRTX
Founder, President, And CEO
Holding Value $1.2M 20,425 shares
Last Trade
Jan 23, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$5.52M 94,057 shares
$58.70
$58.70
Mirati Therapeutics
Mirati Therapeutics MRTX
Founder, President, And CEO
Holding Value $0 0 shares
Last Trade
Jan 23, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$441k 7,520 shares
$58.70
$58.70
Mirati Therapeutics
Mirati Therapeutics MRTX
Founder, President, And CEO
Holding Value $0 0 shares
Last Trade
Jan 23, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$10.8M 168,441 shares
$64.14
$58.70
Mirati Therapeutics
Mirati Therapeutics MRTX
Founder, President, And CEO
Holding Value $0 0 shares
Last Trade
Jan 23, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$4.07M 69,258 shares
$58.70
$58.70
Mirati Therapeutics
Mirati Therapeutics MRTX
Founder, President, And CEO
Holding Value $0 0 shares
Last Trade
Jan 23, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.2M 20,425 shares
$58.70
$58.70
Mirati Therapeutics
Mirati Therapeutics MRTX
Founder, President, And CEO
Holding Value $0 0 shares
Last Trade
Jan 23, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$4.78M 81,458 shares
$58.70
$58.70
Mirati Therapeutics
Mirati Therapeutics MRTX
Founder, President, And CEO
Holding Value $0 0 shares
Last Trade
Jan 23, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$10.5M 178,052 shares
$58.70
$58.70
Mirati Therapeutics
Mirati Therapeutics MRTX
Founder, President, And CEO
Holding Value $0 0 shares
Last Trade
Jan 23, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$6.55M 111,652 shares
$58.70
$58.70

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up